Skip to main content
. Author manuscript; available in PMC: 2018 Sep 15.
Published in final edited form as: ACS Chem Biol. 2017 Aug 22;12(9):2388–2398. doi: 10.1021/acschembio.7b00369

Figure 1.

Figure 1

Domain organization and SPR data. (a) The domain organizations of PKG I and PKG II are shown. The regulatory domains used for SPR are highlighted with corresponding residue numbers. (b) SPR measurements of the PKG Iβ and II R domains for cGMP and analogs. Competition SPR curves are shown for wild type and mutant proteins. (c) Activation of PKG Iβ and II full-length by cGMP analogs.